Comparative drug survival and effectiveness of interleukin-17 inhibitors versus selective interleukin-23 inhibitors following discontinuation of ustekinumab in plaque psoriasis: A retrospective cohort study.

Stelara (ustekinumab) - J&J

Comparative drug survival and effectiveness of interleukin-17 inhibitors versus selective interleukin-23 inhibitors following discontinuation of ustekinumab in plaque psoriasis: A retrospective cohort study. (PubMed, J Am Acad Dermatol) - Sep 12, 2026 - No abstract available
Journal • Retrospective data • Dermatology • Immunology • Psoriasis • IL17A

http://www.ncbi.nlm.nih.gov/pubmed/42726047

Aikaterini Tsentemeidou; Dimitra Kiritsi; Efstratios Vakirlis; Elena Sotiriou; Ilias Papadimitriou; Isidora Chatzigeorgiou; Michael Arabatzis; Nikolaos Chaitidis; Sotirios Chiotis; Stavritsa-Taxiarchoula Varvara

Sep 12, 2026